Green-Mediterranean Diet Trial Reported a Brain-Aging Biomarker Signal

•

Mind & Focus

Share this post

In coverage last updated September 19, 2025, The Economic Times reported lower levels of brain-aging-linked blood proteins among participants following a green-Mediterranean diet in the DIRECT PLUS trial. The report said the research appeared in Clinical Nutrition.

The trial compared three dietary approaches over 18 months

According to The Economic Times, nearly 300 participants took part in the 18-month comparison. Participants were assigned to one of three approaches:

Standard healthy-diet guidance: The comparison approach described in the report.
A Mediterranean diet: A dietary pattern that included vegetables and olive oil alongside whole grains, fish and poultry.
A green-Mediterranean diet: An adaptation of the Mediterranean pattern that added green tea and Mankai shakes.

Mankai is an edible aquatic plant also known as duckweed. In this study report, it was part of a combined dietary approach. The comparison therefore concerned dietary patterns rather than a stand-alone green tea drink or an isolated plant ingredient.

The available coverage does not specify participants’ ages or sex breakdown. That leaves the demographic fit for men in midlife and later life unclear. The participant count alone does not establish how closely this study population matches that audience.

The Economic Times described the research as a collaboration involving Harvard T.H. Chan School of Public Health, Ben-Gurion University of the Negev and the University of Leipzig. Researchers measured blood levels of proteins associated with accelerated brain aging.

That measurement was the focus of the reported analysis. Keeping the trial’s actual measurement in view is useful when reading a headline about food and the aging brain. For broader context, our discussion of diet quality and healthy aging addresses the wider dietary question.

Lower blood-protein levels were the reported finding

The physiological finding described in the coverage was specific:

Participants following the green-Mediterranean diet had lower blood levels of proteins associated with accelerated brain aging, according to The Economic Times.

The association with brain aging is what makes the result relevant to this topic. These were not simply described as routine dietary measurements. The report presented them as biological signals that could help researchers study how eating patterns relate to the aging brain.

Anat Meir, identified as a Harvard Chan School postdoctoral fellow and study co-leader, discussed the possible value of tracking protein changes in blood. According to the article, such monitoring may offer a view of how diet and lifestyle influence brain aging. It may also reveal biological changes before cognitive symptoms appear.

That is the research opportunity behind the finding: using a measurable signal to investigate a process that matters over time. It helps explain why researchers would examine blood proteins in a dietary trial. The signal gives them a specific result to investigate further.

The report also quoted senior author Iris Shai, identified as an adjunct professor of nutrition at Harvard. She discussed green tea, plant-based protein and healthier fats as dietary adjustments that might support cognitive health.

Her comments provide context for the dietary approach. They are not a separate trial result. The distinction matters because an author’s interpretation and a measured outcome serve different roles in a research report: one explains possible relevance while the other describes what was observed.

The coverage leaves the size and clinical meaning unresolved

Several gaps limit how much weight readers can place on the finding. The available article does not provide:

The names of the proteins measured.
Numerical effect sizes showing how large the reported differences were.
Confidence intervals describing the precision of those differences.
Statistical-significance details for the biomarker analysis.

Without those details, readers cannot independently assess the size or reliability of the reported result. A description such as “lower levels” gives the direction of a finding. It does not show whether the difference was small or substantial, or how much uncertainty surrounded it.

The report also does not describe improved memory, better concentration or other cognitive-test gains. Nor does it report fewer cases of dementia. Those are different outcomes from a blood-protein measurement, so the biomarker finding should not be presented as evidence that participants became mentally sharper or avoided disease.

For readers interested in those everyday outcomes, our review of diet research and longer-term cognitive performance addresses a related but distinct evidence question. Keeping the outcome named makes comparisons between nutrition stories more useful.

The proposed explanation remains open too. The Economic Times suggested that anti-inflammatory compounds in green tea and Mankai might help explain the finding. It did not present that mechanism as proven, and it said more research was needed to understand long-term effects.

The dates also need care. The print page is dated October 15, 2026, while the article says it was last updated September 19, 2025. Those displayed dates do not establish when Clinical Nutrition published the underlying analysis, so this is best read as a retrospective look at the reported findings rather than a newly dated trial announcement.

The finding supports further study rather than a new diet rule

For men after 45, the useful takeaway is to keep the claim attached to the measurement. This report concerns a dietary pattern and blood proteins linked to brain aging. That is a worthwhile research lead, with a narrower meaning than a broad claim about preserving mental performance.

The practical interpretation should also stay at the dietary-pattern level. Crediting green tea alone would change the question the reported trial addressed. Crediting Mankai alone would do the same. The green-Mediterranean approach combined those additions with a wider eating pattern.

A useful way to assess similar headlines is to ask what researchers measured before deciding what the result means. Here the answer is blood proteins. The next questions are the size of the difference and its relevance to an outcome that matters in daily life.

This reading does not require dismissing the result. It gives the finding an appropriate place: a promising biological observation that deserves fuller reporting and further investigation. Interest in a dietary approach and confidence in a specific health benefit are separate judgments.

Personal decisions about changing diet for cognitive concerns belong with qualified medical or nutrition care. The report describes research on a dietary pattern, not a treatment plan or a reason to replace individualized advice.

What this changes: This research adds a preliminary biological signal for further investigation rather than altering current best practices for cognitive health.

How Everfitguys helps

Blood-protein findings require a different reading from evidence about daily mental performance, and Everfitguys brings a research-led editorial perspective to that distinction. Its plain-English coverage helps men after 45 assess diet and longevity claims against the available evidence while keeping their interest in lasting mental sharpness in view.

Read the research